Buradasınız

Anasayfa » Content

Preterm Erken Membran Rüptürü Olan Gebelerde Kliniğimizin Perinatal Sonuçları

Perinatal Outcomes of Pregnant Women with Preterm Premature Rupture of Membranes in Our Clinic

Journal Name:

  • Uludağ Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2008

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
The aim of this study was to assess perinatal outcomes of pregnant women who had been admitted to our clinic with the diagnosis of preterm premature rupture of membranes.The study was performed retrospectively on 90 pregnant women who were admitted to and gave birth at the Deparment of Obstetrics and Gynecology, Uludag University Faculty of Medicine, with the diagnosis of preterm premature rupture of membranes. Cases who were enrolled in the study were divided into two groups according to gestational age: women whose gestational ages are between 27 and 34 weeks, and less than and equal to 26 weeks. Complications, frequency of chorioamnionitis, incidence of neonatal morbidity and mortality were assessed. Group 1 and Group 2 included 69(%76,7) and 21 (%23,3) cases, respectively. Antibiotherapy had been used in all study population. While, respectively, 48 (%53,3) and 61(%67,8) women received tocolytic therapy and antenatal corticotherapy, 42(%46,7) and 29 (%32,2) did not. 33(%36,6) neonates needed surfactant therapy. Of 33 neonates, 17(%24,6) were in first group and 16(%76,2) were in second group. Mean gestational age and birth weights were 31,86 and 24,88 weeks, and 1804(±663,4 ) and 805(±55,84) grams in Group 1 and 2, respectiely. Duration of supplemental oxygen was 21,49(±0,91) days in Group 1 and 71,60(±14,81) days in Group 2. Length of hospital stay was 35,77 (±3.57) and 93.65(±15.38) days, respectively. 6 neonates (%8,7) in Group 1 and 5 neonates (%23.8) in Group 2 experienced necroziting enterocolitis (NEC). While incidence of bronchopulmonary dyplasia (BPD) was 10(%14,4) in Group 1, the rate was % 19,04 in Group 2. Rate of patent ductus arteriosus (PDA) was % 4,3 and % 14,3 in Group 1 and Group 2. Grade III-IV intraventricular hemorrhage was more common in Group 2 compared to Group 1; %4.3 in Group 1 and %14.3 in Group 2. In conclusion, it is suggested that the preterm premature rupture of membranes is one of the most important obstetric problems, with negative influences on perinatal outcomes.
Bookmark/Search this post with
Abstract (Original Language): 
Bu çalışmanın amacı kliniğimizde preterm erken membran rüptürü nedeniyle takip edilen gebelerde perinatal sonuçların incelenmesidir. Çalışma; Aralık 2004 – Aralık 2007 tarihleri arasında Uludağ Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı kliniğine preterm erken membran rüptürü tanısı ile yatırılan ve burada doğum yapan 90 olgunun dosya kayıtları incelenerek retrospektif olarak yapıldı. Çalışmaya dahil edilen olgular gebelik haftalarına göre iki gruba ayrıldı. Birinci grubu, 27-34. gebelik haftasında olan olgular ikinci grubu ise 26. gestasyonel hafta ve daha küçük gebelik haftasında olan olgular oluşturuyordu. Bu olgulardaki komplikasyonlar, koryoamnionit sıklığı, yenidoğanlardaki morbidite ve mortalite insidansı incelendi. Olguların 69’u (%76,7) 1. grupta, 21’i (%23,3) 2. grupta yer alıyordu. İncelenen tüm olgulara antibiyoterapi uygulanmış olduğu görüldü. Toplam 48 (%53,3) olguya tokoliz verilmiş, 42 (%46,7) olguya da tokoliz verilmemişti; ayrıca 61 (%67,8) olguya antenatal kortikosteroid uygulanmış, 29 (%32,2) olguya ise uygulanmamıştı. Yenidoğanların 33’üne (%36,6) sürfaktan tedavisi uygulanmıştı. Bunlardan 17’si (%24,6) birinci grupta, 16’sı (%76,2) ikinci grupta yer alıyordu. Birinci gruptaki olguların gebelik yaşı 31,86 hafta, ikinci grupta ise 24,88 idi. Bebek doğum tartıları da sırayla 1 804 (± 663,4) gr ve 805 (± 55,84) gr idi. Yenidoğanların oksijene ihtiyaç duydukları gün sayısı 1. grupta 21,49 gün (± 0,91), 2. grupta ise 71,60 (± 14,81) güdü. Birinci gruptaki olguların hastanede yatış süresi 35,77 gün (± 3.57), ikinci gruptaki olguları ise 93,65 (± 15.38) gündü. Birinci grupta yer alan olgulardan 6’sında (%8.7), ikinci grupta ise 5’inde (%23,8) nekrotizan enterokolit (NEK) gelişmişti. Birinci gruptan 10 olguda (%14,4) bronkopulmoner displazi (BPD) gelişirken 2. grupta bu oran %19,04 idi. Patent duktus arteriozus (PDA) ise birici grupta %4,3 oranında görülürken ikinci grupta %14,3 oranında idi. Grade III-IV intraventriküler kanama (IVK) sıklığı da ikinci grupta birinci gruba göre artmış olup sırasıyla birinci grupta % 4,3, ikinci grupta %14,3 oranında idi. Sonuç olarak preterm erken membran rüptürünün perinatal sonuçları olumsuz etkileyen en önemli obstetrik sorunlardan birisi olduğu düşünüldü.
FULL TEXT (PDF): 
PDF icon arastirmax-preterm-erken-membran-rupturu-olan-gebelerde-klinigimizin-perinatal-sonuclari.pdf
  • 2
71-77
  • Turkish

REFERENCES

References: 

1. Mercer BM, Goldenberg RL, Meis PJ, et al. The Preterm
Prediction Study: prediction of preterm premature rupture of
membranes through clinical findings and ancillary testing. Am
J Obstet Gynecol 2000; 183: 738-49.
2. Garite TJ. Premature rupture of the membranes. In Creasy RK,
Rcsnik R (eds): Maternal and Fetal Medicine, Principles and
Practice. Philadelphia: WB Saunders, 1994: 625-38.
3. Mercer BM. Is there a role for tocolytic therapy during
conservative management of preterm premature rupture of the
membranes? Clin Obstet and Gynecol 2007; 50: 487-96.
4. Mercer BM. Preterm premature rupture of the membranes.
Obstet Gynecol 2003; 101: 178-93.
5. Garite TJ, Spellacy WN. Preterm premature rupture of the
membranes. In: Scott JR, DiSaia PJ, Hammond CB, Spellacy
WN (eds). Danforth's Obstetrics and Gynecology. Seventh
Edition Philadelphia, JB Lippincott; 1994: 305-15.
6. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum
antibiotics for spontaneous preterm labour: the ORACLE II
randomised trial. ORACLE Collaborative Group. Lanset 2001;
357: 989-94.
7. Mercer BM, Goldenberg RL, Das A, et al. The preterm
prediction study: A clinical risk assessment system. Am J
Obstet Gynecol 1996; 174: 1885-95.
8. Joseph KS, Kramer MS, Marcoux S, et al. Determinants of
preterm birth rates in Canada from 1981 through 1983 and from
1992 through 1994. N Engl J Med 1998; 339:1434-9.
9. Mercer BM. Preterm premature rupture of the membranes:
diagnosis and management. Clin Perinatol 2004; 31: 765-82.
10. Garite TJ. Management of premature rupture of membranes.
Clin Perinatol 2001; 28: 837-47.
11. Söylemez F. Erken membran rüptürü. In: Kişnişçi HA, Gökşin
E, Durukan T, Üstay K, Gürgan T, Önderoğlu LS (Eds). Temel
Kadın Hastalıkları ve Doğum Bilgisi. Ankara, 1996: 1481-9.
12. Caroll SG, Papaioannaou S, Nicholaides KH. Assesment of
fetal activity and amniotic fluit volume in the prediction of
intrauterine infection in preterm prelabour amniorrhexis. Am J
Obstet Gynecol 1995; 172: 1427- 35. Preterm Erken Membran Rüptürü
77
13. Vintzileos AM, Campbell WA, Nochimson DJ, et al. Degree of
oligohydramnios and pregnancy outcome in patients with
premature rupture of the membranes. Obstet Gynecol. 1985; 66:
162-7.
14. Vintzileos AM, Campbell WA, Nochimson DJ et al. Qualitative
amniotic fluid volume versus amniocentesis in predicting
infection in preterm premature rupture of the membranes.
Obstet Gynecol 1986; 67: 579-83.
15. Lemons JA, Bauer CR, Oh W, Korones SB et al. Very low birth
weight outcomes of the National Institute of Child health and
human development neonatal research network, January 1995
through December 1996. NICHD Neonatal Research Network.
Pediatrics. 2001; 107:1-8.
16. Türkiye’de yenidoğan bakım ünitelerinde mortalite-2002. Türk
Neonatoloji Derneği Bülteni 2005; 12:10-14.
17. Taylor J, Garite TJ. Premature rupture of membranes before
fetal viability. Obstet Gynecol. 1984; 64: 615-20.
18. Rotschild A, Ling EW, Puterman ML et al. Neonatal outcome
after prolonged preterm rupture of the membranes. Am J Obstet
Gynecol. 1990; 162: 46-52.
19. Simhan HN, Canavan TP. Preterm premature rupture of
membranes: diagnosis, evaluation and management strategies.
BJOG 2005; 112: 32-37.
20. Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in
lung function and disease. N Engl J Med 2002; 347: 2141-8.
21. Rodrigues RJ, Martin RJ, Fanaroff AA. Respiratory Distres
Syndrome and its management. In: Neonatal-Perinatal
Medicine (7th ed). Fanaroff AA, Martin RJ (eds). Mosby, St
Louis: 2002; 1001-11.
22. Bancalari EH. Neonatal Chronic Lung Disease. NeonatalPerinatal Medicine (7th ed). Fanaroff AA, Martin RJ (eds).
Mosby, St Louis: 2002; 1057-70.
23. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment
based on staging criteria. Pediatr Clin North Am 1986; 33: 179-
201.
24. Aagaard-Tillery KM, Nuthalapaty FS, Ramsey PS, Ramin KD.
Preterm premature rupture of membranes: perspectives
surrounding controversies in management. Am J Perinatol
2005; 22: 287-97.
25. Canavan TP, Simhan HN, Caritis S. An evidence-based
approach to the evaluation and treatment of premature rupture
of membranes: Part II. Obstet Gynecol Surv 2004; 59: 678-89.
26. Trochez-Martinez RD, Smith P, Lamont RF. Use of C-reactive
protein as a predictor of chorioamnionitis in preterm prelabour
rupture of membranes BJOG 2007;114: 796-801.
27. Yoon BH, Jun JK, Park KH, et al. Serum C-Reaktive protein,
white blood cell count, and amniotic fluid white blood cell
count in women with preterm premature rupture of membranes.
Obstet. Gynecol 1996; 88: 1034-40.
28. Hansen T, Gorbet A. Respiratory System. In: Taeusch HW,
Ballards RA (eds). Avery’s disease of the Newborn 7 th edition.
Philadelphia. WB Saunders 1998 pp 541-685.
29. Ramsey PS, Lieman JM, Brumfield CG, Carlo W.
Chorioamnionitis increases neonatal morbidity in pregnancies
complicated by preterm premature rupture of membranes. Am J
Obstet Gynecol 2005; 192: 1162-6.
30. Yoshimura S, Masuzaki H, Gotoh H, et al. Ultrasonographic
prediction of lethal pulmonary hypoplasia: comparison of eight
different ultrasonographic parameters. Am J Obstet Gynecol
1996; 75: 477-83.
31. Lauria MR, Gonik B, Romero R. Pulmonary hypoplasia:
pathogenesis, diagnosis, and antenatal prediction. Obstet
Gynecol 1995; 86: 466-75.
32. Moberg LJ, Garite TJ, Freeman RK. Fetal heart rate patterns
and fetal distress in patients with preterm premature rupture of
membranes. Obstet Gynecol 1984; 64: 60-4.
33. Christmas JT, Cox SM, Andrews W et al. Expectant
management of preterm ruptured membranes: effects of
antimicrobial therapy. Obstet Gynecol 1992; 80: 759-62.
34. ACOG practice bulletin. Premature rupture of membranes.
Clinical management guidelines for obstetrician-gynecologists.
Number 1, June 1998. American College of Obstetricians and
Gynecologists. Int J Gynaecol Obstet 1998; 63: 75-84.

Thank you for copying data from http://www.arastirmax.com